Skip to content
Open access

Co-infection models of Staphylococcus aureus and respiratory viruses reveal synergistic interactions counteracted by a bithiazole derivative

Sep 2026 · Frontiers in Cellular and Infection Microbiology · Vol 16 · 0 citations · 41 references
Medicine

TL;DR

The bithiazole compound, MR335, effectively counteracted the synergistic interactions between respiratory viruses and S. aureus at concentration that retained antiviral but not antibacterial activity, suggesting their synergistic cooperation and opening the way to alternative therapies that prevent bacterial superinfection without resorting to conventional antibiotics.

Abstract

Viral-bacterial co-infections represent a major contributor to global morbidity and mortality. In influenza virus infections, secondary bacterial pneumonia occurs in approximately 20–30% of cases and is associated with an increased risk of shock, mechanical ventilation, and even mortality. Bacterial superinfections are frequent causes of mortality in influenza severe infections and have been a major cause of morbidity and mortality also in COVID-19 patients. Staphylococcus aureus has been identified as one of the most prevalent bacterial pathogens among hospitalized and non-hospitalized patients who have tested positive for SARS-CoV-2 or influenza virus infections. Generally, antibiotic therapy is administered to at-risk patients to preclude bacterial over-infections by eliminating susceptible pathogens, increasing selective pressure favoring antibiotic-resistant bacteria. Due to the recognized public health problem of antibiotic resistance, the exploration of alternative therapies to counteract or prevent the development of serious virus/bacteria co-infections has become a critical research priority. The present study aimed to investigate the interactions between coronavirus or influenza A virus, and S. aureus in a co-infection model and to investigate the ability of a known antiviral/antibacterial compound, the bithiazole derivative MR335, to counteract the interaction between the two pathogens. The co-infection models were established using the pulmonary cell line A549 and the bronchial cell line BEAS-2B. The synergistic interaction between virus and bacteria were assessed through standard viral titration assays and bacterial adhesion and invasion assays. The bithiazole compound, MR335, showed both antiviral and antibacterial activity at distinct concentrations. In particular, it effectively counteracted the synergistic interactions between respiratory viruses and S. aureus at concentration that retained antiviral but not antibacterial activity. Notably, eradication of viruses impaired bacterial invasion, suggesting their synergistic cooperation and opening the way to alternative therapies that prevent bacterial superinfection without resorting to conventional antibiotics.

Read PDF

Similar papers

Review Open access Oct 2026

Virulence Mechanisms of Streptococcus pneumoniae During Co-Infection

This review provides a comprehensive overview of the multi-stage progression of pneumococcal invasive disease, from initial colonisation to host barrier migration, and examines environmental triggers that drive the lifestyle switch from commensal to virulent, highlighting the role of other organisms in this stimulation...

Nicholas S. Briggs, S. Camaione, J. Goodall et al. · 0 citations
Review Oct 2026

Phage therapy for bacterial infections of CNS: a pharmacotherapeutic perspective.

Today, owing to its targeted action, adequate tissue distribution and autodosing, phage therapy can serve as an ideal option for addressing hard-to-treat CNS infections caused by antibiotic resistant bacteria, despite of its challenging pharmacokinetics and formulation development.

Ahsan Ibrahim, Fawad Bashir, Syed Damin Abbas Hamdani et al. · 0 citations
Open access Sep 2026

Risk factors for Streptococcus pneumoniae antibiotic resistance in a large industrial city

The resistance of microorganisms to antimicrobials is an important cause of adverse outcomes of infectious diseases. It is important to study various aspects of the epidemic process of the spread of resistant strains of microorganisms. Аim . To evaluate the possible role of various patient-related factors in the de...

S. A. Semenov, G. Khasanova, O. A. Monakova et al. · 0 citations
Review Open access Sep 2026

Multidrug-Resistant Bacterial Infections: A Mini-Review

Multidrug-resistant (MDR) bacterial infections are a major global public-health and sustainable-development challenge. MDR bacteria are generally defined as organisms that are non-susceptible to at least one antimicrobial agent in three or more antimicrobial categories, although definitions may vary by organism and cli...

Joystu Dutta, Abhijit Mitra · 0 citations
Review Open access Sep 2026

The interface of biofilm and immune system for Gram-negative ESKAPE pathogens

ABSTRACT The ESKAPE group of pathogens comprises Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp., which are capable of developing profound biofilms while infecting host tissues and medical devices. In addition to acting as a barr...

Shatarupa Biswas, Sayan Bhattacharyya, Sonali Biswas et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.